Guillain-Barré Syndrome (GBS)
Also known as: Gullain Barre Syndrome / Gullian Barre Syndrome / Guillain-Barré / Guillain-Barre / Guillain-Barré Syndrome / Guillain Barré Syndrome / Guillain-Barre Syndrome (GBS) / Guillian-Barre syndrome / Guillain-Barre Syndrome / Guillain Barre Syndrome / Syndrome Guillain-Barre / Guillain-Barre syndrome (disorder) / Fisher syndrome / Miller Fisher syndrome / Fisher's syndrome (disorder) / Acute Autoimmune Neuropathy / Paralysis ascending / Acute infective polyneuritis (disorder) / Post-infectious polyneuritis (disorder) / Acute infective polyneuritis
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16977 | ANX-005 | 1 | Completed | 1 |
| DB00028 | Human immunoglobulin G | 1 | Completed | 1 |
| DB06637 | Dalfampridine | 2 | Completed | 1 |
| DB01257 | Eculizumab | 2 | Completed | 1 |
| DB01257 | Eculizumab | 2 | Unknown Status | 1 |
| DB15270 | Efgartigimod alfa | 2 | Not Yet Recruiting | 1 |
| DB00028 | Human immunoglobulin G | 2 | Not Yet Recruiting | 1 |
| DB15258 | Imlifidase | 2 | Completed | 1 |
| DB00028 | Human immunoglobulin G | 2 / 3 | Completed | 1 |
| DB16977 | ANX-005 | 3 | Recruiting | 1 |
| DB16128 | Crovalimab | 3 | Withdrawn | 1 |
| DB01257 | Eculizumab | 3 | Completed | 1 |
| DB00028 | Human immunoglobulin G | 3 | Withdrawn | 1 |
| DB00028 | Human immunoglobulin G | 4 | Recruiting | 1 |
| DB00959 | Methylprednisolone | 4 | Recruiting | 1 |
| DB09222 | Fibrinogen human | Not Available | Unknown Status | 1 |
| DB00028 | Human immunoglobulin G | Not Available | Not Yet Recruiting | 1 |